The Latest Headlines at American Banking and Market News
Innoviva, Inc. (NASDAQ:INVA) Sees Significant Decline in Short Interest
Innoviva, Inc. (NASDAQ:INVA – Get Free Report) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 11,330,000 shares, a decrease of 13.0% from... More of this article »
iRobot Co. (NASDAQ:IRBT) Short Interest Update
iRobot Co. (NASDAQ:IRBT – Get Free Report) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 8,230,000 shares, a drop of 12.8% from the March 15th total of 9,440,000 shares. Currently,... More of this article »
Inter Parfums, Inc. (NASDAQ:IPAR) Sees Significant Drop in Short Interest
Inter Parfums, Inc. (NASDAQ:IPAR – Get Free Report) saw a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 377,500 shares, a drop of 12.9% from the March 15th total... More of this article »
Short Interest in Innovative Solutions and Support, Inc. (NASDAQ:ISSC) Grows By 18.5%
Innovative Solutions and Support, Inc. (NASDAQ:ISSC – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 20,500 shares, an increase... More of this article »
Investar Holding Co. (NASDAQ:ISTR) Short Interest Update
Investar Holding Co. (NASDAQ:ISTR – Get Free Report) was the recipient of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 35,900 shares, a decrease of... More of this article »
Head to Head Survey: BlackBerry (NYSE:BB) versus FalconStor Software (OTCMKTS:FALC)
BlackBerry (NYSE:BB – Get Free Report) and FalconStor Software (OTCMKTS:FALC – Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies... More of this article »
Critical Review: MariMed (OTCMKTS:MRMD) versus Cronos Group (NASDAQ:CRON)
MariMed (OTCMKTS:MRMD – Get Free Report) and Cronos Group (NASDAQ:CRON – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength... More of this article »
Critical Analysis: Bank of America (NYSE:BAC) & Nicolet Bankshares (NYSE:NIC)
Bank of America (NYSE:BAC – Get Free Report) and Nicolet Bankshares (NYSE:NIC – Get Free Report) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their... More of this article »
Contrasting Maris-Tech (NASDAQ:MTEKW) and Jabil (NYSE:JBL)
Maris-Tech (NASDAQ:MTEKW – Get Free Report) and Jabil (NYSE:JBL – Get Free Report) are both computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength... More of this article »
Jiangxi Copper (OTCMKTS:JIXAY) vs. Taseko Mines (NYSE:TGB) Head-To-Head Comparison
Taseko Mines (NYSE:TGB – Get Free Report) and Jiangxi Copper (OTCMKTS:JIXAY – Get Free Report) are both basic materials companies, but which is the better business? We will contrast the two businesses based on the strength... More of this article »
Critical Survey: MGT Capital Investments (OTCMKTS:MGTI) and Senmiao Technology (NASDAQ:AIHS)
MGT Capital Investments (OTCMKTS:MGTI – Get Free Report) and Senmiao Technology (NASDAQ:AIHS – Get Free Report) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based... More of this article »
Cadrenal Therapeutics (CVKD) and Its Rivals Critical Review
Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) is one of 983 public companies in the “Pharmaceutical preparations” industry, but how does it compare to its rivals? We will compare Cadrenal Therapeutics to related... More of this article »
Glacier Bancorp, Inc. (NASDAQ:GBCI) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Glacier Bancorp, Inc. (NASDAQ:GBCI – Get Free Report) has received a consensus rating of “Moderate Buy” from the four ratings firms that are currently covering the firm, Marketbeat Ratings reports. Two investment... More of this article »